Protalix BioTherapeutics, Inc. (FRA:PBDA)
2.220
-0.160 (-6.72%)
At close: Mar 6, 2026
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.